These devices, used to repair detached or torn retinas, are made from materials like stainless steel and medical-grade silicone to ensure sterility. Available in various types, including vitrectomy machines, retinal laser equipment, and surgical instruments like cannulas and forceps, they offer quicker setup times and improved patient safety. Additionally, they facilitate tissue replacement and enhance surgeons’ ability to address different eye conditions, contributing to their rising demand worldwide for treating issues like refractive errors, amblyopia, and strabismus.
Expert Insights: Ask Analyst or Download Full Report with TOC and Figures: https://www.renub.com/retinal-surgery-device-market-global-forecast-p.php
According to the WHO’s 2021 data, the global population aged 60 and older is expected to reach 2 billion by 2050, up from 900 million in 2015. Currently, around 125 million people are 80 or older. Factors such as increasing retinal disorders, eye injuries, and diabetic retinopathy contribute to the growth of the retinal surgery device market, driven by PubMed data showing rising blindness and visual impairments in the Middle East and Africa. The forecasted increase in ophthalmic diseases indicates market growth. The increasing inclination towards personalized medicine also impacts the retinal surgery device market. Surgeons are utilizing genetic testing and other diagnostic tools to customize treatment strategies for individual patients, leading to improved treatment outcomes.
The global retinal surgical device market, valued at around US$2.3 billion in 2023, is expected to grow at a CAGR of 7.71% from 2024 to 2030. NCBI research suggests diabetic retinopathy cases will rise to 191.0 million by 2030, with 56.3 million experiencing vision-threatening diabetic retinopathy. Blindness due to diabetic retinopathy varies by region, with higher rates in developed economies like the U.S. and Europe. This underscores the urgent need for retinal surgery devices. Technological advancements drive market growth, particularly in vitrectomy machines, precision instruments, retinal laser devices, and diagnostic equipment like OCT systems, enhancing surgical outcomes and postoperative assessment.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=retinal-surgery-device-market-global-forecast-p.php
- Vitrectomy machines comprised the most significant segment.
- The diabetic retinopathy segment is growing substantially in the retinal surgery device market due to global diabetes prevalence.
- Hospitals are essential participants in the retinal surgery device market.
- North America is expected to dominate the retinal surgery device market significantly.
- Key Players
- Related Reports
- Product – Global Retinal Surgery Device Market breakup in 6 viewpoints:
- Application – Global Retinal Surgery Device Market breakup in 5 viewpoints:
- End-Users – Global Retinal Surgery Device Market breakup in 3 viewpoints:
- Countries – Global Retinal Surgery Device Market breakup in 5 viewpoints:
- All the Key players have been covered from 3 Viewpoints:
- Company Analysis:
Vitrectomy machines comprised the most significant segment.
Vitrectomy machines play a crucial role in the retinal surgery device market due to their effectiveness in treating a wide range of retinal conditions. These devices are essential for removing blood, debris, or scar tissue from the vitreous gel within the eye, addressing issues such as retinal detachment, diabetic retinopathy, macular holes, and vitreous hemorrhage. By enabling surgeons to perform intricate procedures precisely, vitrectomy machines significantly improve patient outcomes and preserve vision. Their versatility and efficacy make them indispensable tools in retinal surgery, driving their importance and demand in the market.
The diabetic retinopathy segment is growing substantially in the retinal surgery device market due to global diabetes prevalence.
The diabetic retinopathy segment is witnessing substantial growth in the retinal surgery device market share, propelled by the escalating prevalence of diabetes worldwide. As diabetes rates continue to rise globally, the demand for effective treatments for diabetic retinopathy, a common complication of diabetes affecting the eyes, is increasing. Retinal surgery devices are critical in addressing diabetic retinopathy, driving their adoption and market growth. With the urgent need to manage diabetic eye complications, including retinopathy, these devices are becoming indispensable tools for ophthalmic surgeons, underscoring their significance in the market landscape.
Hospitals are essential participants in the retinal surgery device market.
Hospitals are key players in the retinal surgery device market, serving as central hubs for surgical interventions and patient care. They are pivotal in providing comprehensive services, including using advanced retinal surgery devices to address various ocular conditions effectively. With their specialized facilities and skilled healthcare professionals, hospitals ensure the delivery of high-quality care and optimal outcomes for patients undergoing retinal surgery. Their central role in the healthcare ecosystem solidifies their dominance in the market, making them indispensable entities driving advancements and innovations in retinal surgical techniques and technologies.
North America is expected to dominate the retinal surgery device market significantly.
North America solidifies its dominance in the retinal surgery device market. With advanced healthcare infrastructure and a robust technological landscape, the region leads in the innovation and adoption of retinal surgery devices. High healthcare spending and a growing senior population contribute to the region’s prominence. Additionally, the presence of key market players and favorable reimbursement policies further bolster North America’s position. Through cutting-edge research and development and widespread access to advanced medical facilities, North America continues to spearhead advancements in retinal surgery technology, cementing its leadership role in the global market.
Key Players
Topcon Corporation, Alcon AG, Carl Zeiss, Bausch Health Companies Inc., Iridex Corporation, Escalon Medicals, Quantel Medical, and Rhein Medical, Inc. are renowned players in the retinal surgery device market.
Related Reports
Cardiovascular Surgical Devices Market: https://www.renub.com/cardiovascular-surgical-device-market-p.php
Cosmetic Surgery Market: https://www.renub.com/cosmetic-surgery-market-p.php
Liposuction Surgery Device Market: https://www.renub.com/liposuction-surgery-devices-market-p.php
Lung Cancer Diagnostics Market: https://www.renub.com/lung-cancer-diagnostics-market-p.php
Product – Global Retinal Surgery Device Market breakup in 6 viewpoints:
- Vitrectomy Machines
- Vitrectomy Packs
- Surgical Instruments
- Microscopic Illumination Equipment
- Retinal Laser Equipment
- Others
Application – Global Retinal Surgery Device Market breakup in 5 viewpoints:
- Diabetic Retinopathy
- Retinal Detachment
- Epiretinal Membrane
- Macular Hole
- Others
End-Users – Global Retinal Surgery Device Market breakup in 3 viewpoints:
- Hospitals
- Eye Clinics
- Others
Countries – Global Retinal Surgery Device Market breakup in 5 viewpoints:
- North America
1.1 United States
1.2 Canada
- Europe
2.1 France
2.2 Germany
2.3 Italy
2.4 Spain
2.5 United Kingdom
2.6 Belgium
2.7 Netherland
2.8 Turkey
- Asia Pacific
3.1 China
3.2 Japan
3.3 India
3.4 South Korea
3.5 Thailand
3.6 Malaysia
3.7 Indonesia
3.8 Australia
3.9 New Zealand
- Latin America
4.1 Brazil
4.2 Mexico
4.3 Argentina
- Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 South Africa
All the Key players have been covered from 3 Viewpoints:
- Overview
- Recent Development
- Revenue Analysis
Company Analysis:
- Topcon Corporation
- Alcon AG
- Carl Zeiss
- Bausch Health Companies Inc
- Iridex Corporation
- Escalon Medicals
- Quantel Medical
- Rhein Medical, Inc
About the Company:
Renub Research is a Market Research and Information Analysis company with more than 15 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 9000 syndicated reports and worked on more than 750 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.
Media Contact:
Company Name: Renub Research
Contact Person: Rajat Gupta, Marketing Manager
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Address: 225 Kristie Ln, Roswell, GA 30076
Email: info@renub.com
LinkedIn: https://linkedin.com/company/renub-research
Website: www.renub.com